Photo of Francisco Rojas, Business Development Manager, RetinaRisk, Michael Rutzler, CEO, ApoGlyx and Trude Tingvoll, CEO, Respinor

The three Rising Stars, Swedish ApoGlyx, Norwegian Respinor and Icelandic RetinaRisk, share their companies’ histories and journeys so far and also, their advice to other life science entrepreneurs.

Following a long review of the applications by a pan-Nordic committee of industry leaders, 80 Rising Stars were selected to pitch to investors across three dedicated tracks: biotech/pharma, medtech/diagnostics and digital/e-health. One company from each track was selected as the category winner during the NLSInvest event, April 19th.

The “best of the best” of our entrepreneurs

This year’s NLSInvest Rising Star Awards are sponsored by SwedenBIO and BioInnovation Institute (BII), an international life science entrepreneurship initiative and part of the NLSInvest Committee.

“We believe the Nordic ecosystem has all the ingredients required for success and are happy to see international investor interest in the NLSInvest Rising Star companies. Our view is that high-growth Nordic start-up companies must play on a global playing field, and the Rising Star Award is a step in that direction. We wish the participants and the winners of the competition continued success,” says Bobby Soni, Chief Business Officer at BioInnovation Institute.

“We look upon this as the Olympics of life science innovation, where each Nordic country’s strength in this field is proudly demonstrated by the “best of the best” of our entrepreneurs,” says Helena Strigård, CEO of SwedenBIO, the Swedish Life science Industry organization and host of NLSInvest / NLSDays.

For full Interview profiling RESPINOR, follow the link: https://nordiclifescience.org/interview-the-winners-of-the-nlsinvest-rising-star-award/

‍